Mononeuropathy Multiplex After COVID-19.
J Clin Neuromuscul Dis
; 23(1): 24-30, 2021 Sep 01.
Article
in English
| MEDLINE | ID: covidwho-1371756
ABSTRACT
OBJECTIVES:
COVID-19 is a novel coronavirus that emerged in 2019 and is responsible for a global pandemic. Numerous neurologic manifestations have been described in the literature regarding COVID-19, but most studies are focused on the central nervous system. The authors have noted an association between prior COVID-19 infection and the development of a systemic neuropathy that manifests with asymmetric sensorimotor loss in the peripheral nervous system. We describe 4 cases of mononeuropathy multiplex that were diagnosed after COVID-19 infection.METHODS:
All patients included were treated for severe COVID-19 infection at New York Presbyterian Hospital and subsequently referred to the Columbia Peripheral Neuropathy Center for persistent neuropathy.RESULTS:
Patient history, COVID-19 disease course, and mononeuropathy multiplex diagnostic evaluation of the 4 patients are recounted.CONCLUSIONS:
We postulate a connection between COVID-19 and the development of mononeuropathy multiplex with implications in prognostication, rehabilitation strategies, and future treatments.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Mononeuropathies
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
J Clin Neuromuscul Dis
Journal subject:
Physiology
/
Neurology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS